Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AIM ImmunoTech Inc.
Report date December 31, 2024 · Filed January 03, 2025
Section 16 reporting ended · disclosed 2025-01-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 388,729 |
Reported balance
After 2024-12-31 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-12-31 · Grant · Acquired 8,768 · Balance 388,729 F1: The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2024 Filed Jan 3, 2025 21:35 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 8,768 | $0.20 | $1,736.06 |
DisclosureSEC source: 0001493152-25-000270 · ownership.xml · nonDerivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 388,729 F1 · balance_after: The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 22:00 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 24,452 | $0.21 | $5,208.28 |
DisclosureSEC source: 0001493152-24-050436 · ownership.xml · nonDerivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 379,961 F1 · balance_after: The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 23:33 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 22,645 | $0.23 | $5,208.35 |
DisclosureSEC source: 0001493152-24-048536 · ownership.xml · nonDerivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 344,397 F1 · balance_after: These shares are issue in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | PurchaseCommon Stock | 11,111 | $0.21 | $2,355.53 |
DisclosureSEC source: 0001493152-24-048663 · ownership.xml · nonDerivative · entry 2 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 355,509 Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | PurchaseCommon Stock | 1 | $0.21 | $0.21 |
DisclosureSEC source: 0001493152-24-048663 · ownership.xml · nonDerivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 344,398 F1 · shares: The reporting person did not intend this purchase. Read SEC document |
| November 20, 2024 Filed Nov 21, 2024 17:02 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | PurchaseCommon Stock | 81,953 | $0.19 | $15,816.93 |
DisclosureSEC source: 0001493152-24-047092 · ownership.xml · nonDerivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 321,752 Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 19:01 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | PurchaseCommon Stock | 90,910 | $0.33 | $30,000.30 |
DisclosureSEC source: 0001493152-24-010266 · ownership.xml · nonDerivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,765 Read SEC document |
| March 10, 2023 Filed Mar 10, 2023 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherCommon Stock | 68,208 | $1.23 | $83,895.84 |
DisclosureSEC source: 0001493152-23-007238 · ownership.xml · nonDerivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,855 F5 · kind: Reporting person transferred common stock to former spouse in a matrimonial matter. F6 · price: Cost basis of the weighted average share price. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherOptions · Derivative | 25,000 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001493152-23-007238 · ownership.xml · derivative · entry 22 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: CommonStock · 25,000 shares Expires 2032-03-03 F1 · security: Replacement for previously issued options. F3 · date: Date of re-issuance. F4 · kind: Reporting person transferred options to former spouse in a matrimonial matter. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherOptions · Derivative | 25,000 | $0.00 Strike: $1.71 | $0.00 |
DisclosureSEC source: 0001493152-23-007238 · ownership.xml · derivative · entry 21 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: CommonStock · 25,000 shares Expires 2031-11-11 F1 · security: Replacement for previously issued options. F3 · date: Date of re-issuance. F4 · kind: Reporting person transferred options to former spouse in a matrimonial matter. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherOptions · Derivative | 25,000 | $0.00 Strike: $2.77 | $0.00 |
DisclosureSEC source: 0001493152-23-007238 · ownership.xml · derivative · entry 20 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: CommonStock · 25,000 shares Expires 2030-08-12 F1 · security: Replacement for previously issued options. F3 · date: Date of re-issuance. F4 · kind: Reporting person transferred options to former spouse in a matrimonial matter. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherOptions · Derivative | 568 | $0.00 Strike: $9.68 | $0.00 |
DisclosureSEC source: 0001493152-23-007238 · ownership.xml · derivative · entry 19 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 568 Underlying: CommonStock · 568 shares Expires 2029-01-28 F1 · security: Replacement for previously issued options. F2 · derivative.exercise_price: Conversion price reflects reverse split that occurred after original issuance but prior to the date hereof. F3 · date: Date of re-issuance. F4 · kind: Reporting person transferred options to former spouse in a matrimonial matter. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherOptions · Derivative | 2,356 | $0.00 Strike: $9.68 | $0.00 |
DisclosureSEC source: 0001493152-23-007238 · ownership.xml · derivative · entry 18 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,356 Underlying: CommonStock · 2,356 shares Expires 2029-01-28 F1 · security: Replacement for previously issued options. F2 · derivative.exercise_price: Conversion price reflects reverse split that occurred after original issuance but prior to the date hereof. F3 · date: Date of re-issuance. F4 · kind: Reporting person transferred options to former spouse in a matrimonial matter. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherOptions · Derivative | 11 | $0.00 Strike: $9.68 | $0.00 |
DisclosureSEC source: 0001493152-23-007238 · ownership.xml · derivative · entry 17 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11 Underlying: CommonStock · 11 shares Expires 2028-11-14 F1 · security: Replacement for previously issued options. F2 · derivative.exercise_price: Conversion price reflects reverse split that occurred after original issuance but prior to the date hereof. F3 · date: Date of re-issuance. F4 · kind: Reporting person transferred options to former spouse in a matrimonial matter. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherOptions · Derivative | 1,963 | $0.00 Strike: $9.68 | $0.00 |
DisclosureSEC source: 0001493152-23-007238 · ownership.xml · derivative · entry 16 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,963 Underlying: CommonStock · 1,963 shares Expires 2028-10-17 F1 · security: Replacement for previously issued options. F2 · derivative.exercise_price: Conversion price reflects reverse split that occurred after original issuance but prior to the date hereof. F3 · date: Date of re-issuance. F4 · kind: Reporting person transferred options to former spouse in a matrimonial matter. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherOptions · Derivative | 1,115 | $0.00 Strike: $13.64 | $0.00 |
DisclosureSEC source: 0001493152-23-007238 · ownership.xml · derivative · entry 15 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,115 Underlying: CommonStock · 1,115 shares Expires 2028-07-18 F1 · security: Replacement for previously issued options. F2 · derivative.exercise_price: Conversion price reflects reverse split that occurred after original issuance but prior to the date hereof. F3 · date: Date of re-issuance. F4 · kind: Reporting person transferred options to former spouse in a matrimonial matter. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherOptions · Derivative | 1,728 | $0.00 Strike: $13.20 | $0.00 |
DisclosureSEC source: 0001493152-23-007238 · ownership.xml · derivative · entry 14 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,728 Underlying: CommonStock · 1,728 shares Expires 2028-05-16 F1 · security: Replacement for previously issued options. F2 · derivative.exercise_price: Conversion price reflects reverse split that occurred after original issuance but prior to the date hereof. F3 · date: Date of re-issuance. F4 · kind: Reporting person transferred options to former spouse in a matrimonial matter. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherOptions · Derivative | 1,136 | $0.00 Strike: $13.20 | $0.00 |
DisclosureSEC source: 0001493152-23-007238 · ownership.xml · derivative · entry 13 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,136 Underlying: CommonStock · 1,136 shares Expires 2028-05-16 F1 · security: Replacement for previously issued options. F2 · derivative.exercise_price: Conversion price reflects reverse split that occurred after original issuance but prior to the date hereof. F3 · date: Date of re-issuance. F4 · kind: Reporting person transferred options to former spouse in a matrimonial matter. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherOptions · Derivative | 1,136 | $0.00 Strike: $16.72 | $0.00 |
DisclosureSEC source: 0001493152-23-007238 · ownership.xml · derivative · entry 12 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,136 Underlying: CommonStock · 1,136 shares Expires 2028-04-12 F1 · security: Replacement for previously issued options. F2 · derivative.exercise_price: Conversion price reflects reverse split that occurred after original issuance but prior to the date hereof. F3 · date: Date of re-issuance. F4 · kind: Reporting person transferred options to former spouse in a matrimonial matter. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherOptions · Derivative | 2,568 | $0.00 Strike: $16.28 | $0.00 |
DisclosureSEC source: 0001493152-23-007238 · ownership.xml · derivative · entry 11 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,568 Underlying: CommonStock · 2,568 shares Expires 2028-02-13 F1 · security: Replacement for previously issued options. F2 · derivative.exercise_price: Conversion price reflects reverse split that occurred after original issuance but prior to the date hereof. F3 · date: Date of re-issuance. F4 · kind: Reporting person transferred options to former spouse in a matrimonial matter. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherOptions · Derivative | 338 | $0.00 Strike: $15.84 | $0.00 |
DisclosureSEC source: 0001493152-23-007238 · ownership.xml · derivative · entry 10 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338 Underlying: CommonStock · 338 shares Expires 2027-08-31 F1 · security: Replacement for previously issued options. F2 · derivative.exercise_price: Conversion price reflects reverse split that occurred after original issuance but prior to the date hereof. F3 · date: Date of re-issuance. F4 · kind: Reporting person transferred options to former spouse in a matrimonial matter. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherOptions · Derivative | 295 | $0.00 Strike: $18.04 | $0.00 |
DisclosureSEC source: 0001493152-23-007238 · ownership.xml · derivative · entry 9 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295 Underlying: CommonStock · 295 shares Expires 2027-08-15 F1 · security: Replacement for previously issued options. F2 · derivative.exercise_price: Conversion price reflects reverse split that occurred after original issuance but prior to the date hereof. F3 · date: Date of re-issuance. F4 · kind: Reporting person transferred options to former spouse in a matrimonial matter. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherOptions · Derivative | 287 | $0.00 Strike: $18.48 | $0.00 |
DisclosureSEC source: 0001493152-23-007238 · ownership.xml · derivative · entry 8 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287 Underlying: CommonStock · 287 shares Expires 2027-07-31 F1 · security: Replacement for previously issued options. F2 · derivative.exercise_price: Conversion price reflects reverse split that occurred after original issuance but prior to the date hereof. F3 · date: Date of re-issuance. F4 · kind: Reporting person transferred options to former spouse in a matrimonial matter. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherOptions · Derivative | 250 | $0.00 Strike: $21.12 | $0.00 |
DisclosureSEC source: 0001493152-23-007238 · ownership.xml · derivative · entry 7 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: CommonStock · 250 shares Expires 2027-07-15 F1 · security: Replacement for previously issued options. F2 · derivative.exercise_price: Conversion price reflects reverse split that occurred after original issuance but prior to the date hereof. F3 · date: Date of re-issuance. F4 · kind: Reporting person transferred options to former spouse in a matrimonial matter. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherOptions · Derivative | 196 | $0.00 Strike: $21.56 | $0.00 |
DisclosureSEC source: 0001493152-23-007238 · ownership.xml · derivative · entry 6 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196 Underlying: CommonStock · 196 shares Expires 2027-06-30 F1 · security: Replacement for previously issued options. F2 · derivative.exercise_price: Conversion price reflects reverse split that occurred after original issuance but prior to the date hereof. F3 · date: Date of re-issuance. F4 · kind: Reporting person transferred options to former spouse in a matrimonial matter. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherOptions · Derivative | 196 | $0.00 Strike: $21.56 | $0.00 |
DisclosureSEC source: 0001493152-23-007238 · ownership.xml · derivative · entry 5 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196 Underlying: CommonStock · 196 shares Expires 2027-06-15 F1 · security: Replacement for previously issued options. F2 · derivative.exercise_price: Conversion price reflects reverse split that occurred after original issuance but prior to the date hereof. F3 · date: Date of re-issuance. F4 · kind: Reporting person transferred options to former spouse in a matrimonial matter. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherOptions · Derivative | 163 | $0.00 Strike: $25.96 | $0.00 |
DisclosureSEC source: 0001493152-23-007238 · ownership.xml · derivative · entry 4 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163 Underlying: CommonStock · 163 shares Expires 2027-05-31 F1 · security: Replacement for previously issued options. F2 · derivative.exercise_price: Conversion price reflects reverse split that occurred after original issuance but prior to the date hereof. F3 · date: Date of re-issuance. F4 · kind: Reporting person transferred options to former spouse in a matrimonial matter. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherOptions · Derivative | 150 | $0.00 Strike: $28.16 | $0.00 |
DisclosureSEC source: 0001493152-23-007238 · ownership.xml · derivative · entry 3 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150 Underlying: CommonStock · 150 shares Expires 2027-05-15 F1 · security: Replacement for previously issued options. F2 · derivative.exercise_price: Conversion price reflects reverse split that occurred after original issuance but prior to the date hereof. F3 · date: Date of re-issuance. F4 · kind: Reporting person transferred options to former spouse in a matrimonial matter. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherOptions · Derivative | 143 | $0.00 Strike: $29.48 | $0.00 |
DisclosureSEC source: 0001493152-23-007238 · ownership.xml · derivative · entry 2 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143 Underlying: CommonStock · 143 shares Expires 2027-04-30 F1 · security: Replacement for previously issued options. F2 · derivative.exercise_price: Conversion price reflects reverse split that occurred after original issuance but prior to the date hereof. F3 · date: Date of re-issuance. F4 · kind: Reporting person transferred options to former spouse in a matrimonial matter. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 12:30 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | PurchaseCommon Stock | 80,646 | $0.31 | $25,000.26 |
DisclosureSEC source: 0001493152-23-000212 · ownership.xml · nonDerivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,063 Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 21:50 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantOptions · Derivative | 50,000 | $0.00 Strike: $0.41 | $0.00 |
DisclosureSEC source: 0001493152-22-034331 · ownership.xml · derivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-11-30 F1 · security: Annual Independent Director Compensation. Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 19:46 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 24,500 | $1.07 | $26,215.00 |
DisclosureSEC source: 0001702626-22-000006 · primary_doc.xml · nonDerivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,417 Read SEC document |
| March 03, 2022 Filed Mar 4, 2022 14:59 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantOptions · Derivative | 50,000 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001702626-22-000001 · primary_doc.xml · derivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-03-03 Read SEC document |
| November 24, 2021 Filed Nov 24, 2021 18:57 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 19,379 | $1.29 | $24,998.91 |
DisclosureSEC source: 0001702626-21-000003 · primary_doc.xml · nonDerivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,917 Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 22:04 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantOptions · Derivative | 50,000 | $0.00 Strike: $1.71 | $0.00 |
DisclosureSEC source: 0001450324-21-000005 · primary_doc.xml · derivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-11-11 Read SEC document |
| February 25, 2021 Filed Feb 25, 2021 20:07 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | PurchaseCommon Stock | 10,638 | $2.35 | $24,999.30 |
DisclosureSEC source: 0001191434-21-000001 · primary_doc.xml · nonDerivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,538 Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 19:32 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantOptions · Derivative | 50,000 | $0.00 Strike: $2.77 | $0.00 |
DisclosureSEC source: 0001702626-20-000001 · primary_doc.xml · derivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-08-12 Read SEC document |
| December 13, 2019 Filed Dec 16, 2019 18:28 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherCommon Stock | 8,358 | $0.45 | $3,801.22 |
DisclosureSEC source: 0001191434-19-000021 · primary_doc.xml · nonDerivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,326 F1 · kind: Shares issued for 50 percent of Director's fee for the first half of December, 2019. Read SEC document |
| November 29, 2019 Filed Dec 2, 2019 17:57 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherCommon Stock | 9,503 | $0.40 | $3,801.20 |
DisclosureSEC source: 0001450324-19-000027 · primary_doc.xml · nonDerivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,968 F1 · kind: Shares issued for 50 percent of Director's Fee for the second half of November, 2019. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 21:22 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherCommon Stock | 8,264 | $0.46 | $3,801.44 |
DisclosureSEC source: 0001450324-19-000022 · primary_doc.xml · nonDerivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,465 F1 · kind: Shares issued for 50 percent of Director's Fee for the first half of November, 2019. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 15:16 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherCommon Stock | 7,603 | $0.50 | $3,801.50 |
DisclosureSEC source: 0001191434-19-000019 · primary_doc.xml · nonDerivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,201 F1 · kind: Shares issued for 50 percent of Director's Fee for the second half of October, 2019. Read SEC document |
| October 17, 2019 Filed Oct 17, 2019 20:57 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherCommon Stock | 6,911 | $0.55 | $3,801.05 |
DisclosureSEC source: 0001450324-19-000015 · primary_doc.xml · nonDerivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,598 F1 · kind: Shares issued for 50 percent of Director's Fee for the first half of October, 2019. Read SEC document |
| October 02, 2019 Filed Oct 4, 2019 16:43 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherCommon Stock | 5,002 | $0.76 | $3,801.52 |
DisclosureSEC source: 0001191434-19-000017 · primary_doc.xml · nonDerivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,687 F1 · kind: Shares issued for 50 percent of Director's Fee for the second half of September, 2019. Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 18:00 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherCommon Stock | 2,033 | $1.87 | $3,801.71 |
DisclosureSEC source: 0001191434-19-000015 · primary_doc.xml · nonDerivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,685 F1 · kind: Shares issued for 50 percent of Director's Fee for the first half of September, 2019. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 17:36 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherCommon Stock | 2,112 | $1.80 | $3,801.60 |
DisclosureSEC source: 0001191434-19-000013 · primary_doc.xml · nonDerivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,652 F1 · kind: Shares issued for 50 percent of Director's Fee for the second half of August, 2019. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 15:20 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | OtherCommon Stock | 2,001 | $1.90 | $3,801.90 |
DisclosureSEC source: 0001191434-19-000011 · primary_doc.xml · nonDerivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,540 F1 · kind: Shares issued for 50 percent of Director's fee for the first half of August, 2019. Read SEC document |
| July 31, 2019 Filed Aug 2, 2019 16:33 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | OtherCommon Stock | 1,618 | $2.35 | $3,802.30 |
DisclosureSEC source: 0001702626-19-000007 · primary_doc.xml · nonDerivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,539 F1 · kind: Shares issued for 50 percent of Director's Fee for the second half of July, 2019. Read SEC document |
| July 16, 2019 Filed Jul 18, 2019 16:58 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | OtherCommon Stock | 920 | $4.13 | $3,799.60 |
DisclosureSEC source: 0001191434-19-000009 · primary_doc.xml · nonDerivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,494 F1 · kind: Shares issued for 50 percent of Director's Fee for the first half of July, 2019. Read SEC document |
| July 03, 2019 Filed Jul 8, 2019 18:11 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | OtherCommon Stock | 866 | $4.39 | $3,801.74 |
DisclosureSEC source: 0001191434-19-000007 · primary_doc.xml · nonDerivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,574 F1 · kind: Shares issued for 50 percent of Director's Fee for the second half of June, 2019. Read SEC document |
| June 21, 2019 Filed Jun 25, 2019 14:19 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | PurchaseCommon Stock | 9,677 | $4.03 | $38,998.31 |
DisclosureSEC source: 0001702626-19-000003 · primary_doc.xml · nonDerivative · entry 1 APPELROUTH STEWART · CIK 0001702626 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,708 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.